Chicago, IL (PRWEB) May 29, 2013
The birth control safety advocates at DrugRisks.com are announcing a new resource center for patients who have taken the contraceptives Yaz or Yasmin. The site contains warnings about the drugs’ alleged link to blood clots and compensation offered by Bayer for victims.
DrugRisks was created to give patients taking popular prescription drugs like Yaz and Yasmin the latest warnings, recalls, studies and legal news. With access to clear information, patients can discuss side effect concerns with their doctor and decide if they need legal advice.
The resource center contains studies from the British Medical Journal* and FDA** showing patients taking birth control pills containing drospirenone, like Yaz and Yasmin, may have an increased risk of developing blood clots.
With a growing number of patients filing a Yaz lawsuit alleging blood clot injuries, cases were consolidated to a special federal Multi-District Litigation court in Illinois (Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois).
DrugRisks has also learned that the maker of Yaz and Yasmin, Bayer, has spent nearly $1 billion so far to settle around 4,800 claims alleging Yaz blood clots, and will continue to evaluate new claims for settlement on a case-by-case basis***.
Although a federal court recently opened up competition for Yaz from generics****, DrugRisks cautions patients that blood clots have been linked to the chemical drospirenone, which is used in both brand name and generic formulations.
Lawyers are still helping those affected file a claim. Anyone who suffered a blood clot, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin is urged to contact the DrugRisks Center or speak with a lawyer about their legal options.
Copyright©2012 Vocus, Inc.
All rights reserved